Abstract
1. The availability of the non-peptide delta-opioid receptor antagonist naltrindole has provided the possibility for in vivo studies on the function of delta-opioid receptors. We have studied the effects of naltrindole on swim-stress-induced antinociception in adult and neonatal rats. 2. Adult, 25 and 20 day old rats were stressed by warm water (20 degrees C) swimming for 3 min periods and antinociception was assessed by the tail immersion test (50 degrees C). 3. Naltrindole (0.5 and 1 mg kg-1) antagonized swim-stress-induced antinociception in adult and 25 day old rats but in 20 day old rats naltrindole (1 mg kg-1) was without effect. 4. Antinociception induced by the highly mu-opioid receptor selective agonist alfentanil was completely antagonized by naloxone (1 mg kg-1) but virtually unaffected by naltrindole (1 mg kg-1). 5. Neither naloxone nor naltrindole (1 mg kg-1) antagonized swim-stress-induced rises in plasma corticosterone in adult rats at the time of peak antinociception. 6. In conclusion, naltrindole shows in vivo antagonism of opioid-mediated responses. Swim-stress-induced antinociception is mediated through the delta-opioid receptor in 25 day old and adult rats and through the mu-opioid site in 20 day old animals.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Akil H., Young E., Walker J. M., Watson S. J. The many possible roles of opioids and related peptides in stress-induced analgesia. Ann N Y Acad Sci. 1986;467:140–153. doi: 10.1111/j.1749-6632.1986.tb14625.x. [DOI] [PubMed] [Google Scholar]
- Cotton R., Giles M. G., Miller L., Shaw J. S., Timms D. ICI 174864: a highly selective antagonist for the opioid delta-receptor. Eur J Pharmacol. 1984 Jan 27;97(3-4):331–332. doi: 10.1016/0014-2999(84)90470-9. [DOI] [PubMed] [Google Scholar]
- Hart S. L., Slusarczyk H., Smith T. W. The effects of selective opioid delta-receptor antagonists on stress-induced antinociception and plasma corticosterone levels in mice. Neuropeptides. 1985 Feb;5(4-6):303–306. doi: 10.1016/0143-4179(85)90013-7. [DOI] [PubMed] [Google Scholar]
- Heyman J. S., Mulvaney S. A., Mosberg H. I., Porreca F. Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice. Brain Res. 1987 Sep 8;420(1):100–108. doi: 10.1016/0006-8993(87)90244-7. [DOI] [PubMed] [Google Scholar]
- JANSSEN P. A., NIEMEGEERS C. J., DONY J. G. The inhibitory effect of fentanyl and other morphine-like analgesics on the warm water induced tail withdrawl reflex in rats. Arzneimittelforschung. 1963 Jun;13:502–507. [PubMed] [Google Scholar]
- Jackson H. C., Kitchen I. Swim-stress-induced antinociception in young rats. Br J Pharmacol. 1989 Mar;96(3):617–622. doi: 10.1111/j.1476-5381.1989.tb11860.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- James I. F., Goldstein A. Site-directed alkylation of multiple opioid receptors. I. Binding selectivity. Mol Pharmacol. 1984 May;25(3):337–342. [PubMed] [Google Scholar]
- Kitchen I., McDowell J., Winder C., Wilson J. M. Low-level lead exposure alters morphine antinociception in neonatal rats. Toxicol Lett. 1984 Aug;22(2):119–123. doi: 10.1016/0378-4274(84)90054-7. [DOI] [PubMed] [Google Scholar]
- Kitchen I., Rowan K. M. Differences in the effects of mu- and delta-opioid receptor antagonists upon plasma corticosterone levels in stressed mice. Eur J Pharmacol. 1984 May 18;101(1-2):153–156. doi: 10.1016/0014-2999(84)90042-6. [DOI] [PubMed] [Google Scholar]
- Lewis J. W., Cannon J. T., Liebeskind J. C. Opioid and nonopioid mechanisms of stress analgesia. Science. 1980 May 9;208(4444):623–625. doi: 10.1126/science.7367889. [DOI] [PubMed] [Google Scholar]
- Lord J. A., Waterfield A. A., Hughes J., Kosterlitz H. W. Endogenous opioid peptides: multiple agonists and receptors. Nature. 1977 Jun 9;267(5611):495–499. doi: 10.1038/267495a0. [DOI] [PubMed] [Google Scholar]
- McDowell J., Kitchen I. Ontogenesis of delta-opioid receptors in rat brain using [3H][D-Pen2,D-Pen5]enkephalin as a binding ligand. Eur J Pharmacol. 1986 Sep 9;128(3):287–289. doi: 10.1016/0014-2999(86)90780-6. [DOI] [PubMed] [Google Scholar]
- Paterson S. J., Robson L. E., Kosterlitz H. W. Classification of opioid receptors. Br Med Bull. 1983 Jan;39(1):31–36. doi: 10.1093/oxfordjournals.bmb.a071787. [DOI] [PubMed] [Google Scholar]
- Portoghese P. S., Sultana M., Takemori A. E. Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist. Eur J Pharmacol. 1988 Jan 27;146(1):185–186. doi: 10.1016/0014-2999(88)90502-x. [DOI] [PubMed] [Google Scholar]
- Rodriguez R. E., Leighton G., Hill R. G., Hughes J. In vivo evidence for spinal delta-opiate receptor operated antinociception. Neuropeptides. 1986 Oct;8(3):221–241. doi: 10.1016/0143-4179(86)90050-8. [DOI] [PubMed] [Google Scholar]
- Shaw J. S., Miller L., Turnbull M. J., Gormley J. J., Morley J. S. Selective antagonists at the opiate delta-receptor. Life Sci. 1982 Sep 20;31(12-13):1259–1262. doi: 10.1016/0024-3205(82)90356-3. [DOI] [PubMed] [Google Scholar]
- Williams J. G., Brown J. H., Pleuvry B. J. Alfentanil: a study of its analgesic activity and interactions with morphine in the mouse. Br J Anaesth. 1982 Jan;54(1):81–85. doi: 10.1093/bja/54.1.81. [DOI] [PubMed] [Google Scholar]
- Yeadon M., Kitchen I. Comparative binding of mu and delta selective ligands in whole brain and pons/medulla homogenates from rat: affinity profiles of fentanyl derivatives. Neuropharmacology. 1988 Apr;27(4):345–348. doi: 10.1016/0028-3908(88)90141-4. [DOI] [PubMed] [Google Scholar]